Drug
Diatrizoate clinical trials
Includes 10 studies of Diatrizoate Meglumine.
- studies test it
- 10
- open now
- 1
- in phase 3
- 3
- first study started
- 2003
Keep track of what changes. Save the Diatrizoate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStudies by the year they started
10 studies that test it; most in 2003 (1)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 3
- Phase 4
- 5
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 9
Region Skane (1) · Medtronic - MITG (1) · Nadja Haiden,MD (1) · Hospital Universitari de Bellvitge (1) · University of Auckland, New Zealand (1) · University Hospital, Rouen (1) · University of Bologna (1) · University of California, Los Angeles (1)
Often tested with
Tested in the same studies.
Polyethylene Glycols (1) · Ascorbic Acid (1) · Picosulfate sodium (1) · Prucalopride (1) · Sodium Sulfate/Potassium Sulfate/Magnesium Sulfate-based Laxative (1)
Studies
Open first, then newest update. How each study uses Diatrizoate is read from its arms, and is right about nine times in ten.
Testing it · 10
- Optimizing Treatment of Adhesive Small Bowel ObstructionRecruitingPhase 3University of California, Los AngelesNCT06182319Written as Gastrografin
- Bowel Preparation Regimen for Colon Capsule Endoscopy ProcedureCompletedPhase 3Region SkaneNCT05726097Written as gastrografin
- The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.WithdrawnPhase 4London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sNCT03334578Written as Gastrografin
- The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel ObstructionStatus unknownNot applicableJinling Hospital, ChinaNCT03642288Written as Gastrografin
- Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy ProcedureCompletedNot applicableMedtronic - MITGNCT02481219Written as SUPREP oral sulfate solution with Gastrografin
- Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight InfantsCompletedPhase 4Nadja Haiden,MDNCT01515696Written as Gastrografin
- Study of the Effect of Water Soluble Oral Contrast (Gastrografin) on Postoperative Ileus After Colorectal SurgeryCompletedPhase 4Hospital Universitari de BellvitgeNCT01440712Written as Gastrografin
- Gastrografin in Postoperative IleusCompletedPhase 2/3University of Auckland, New ZealandNCT01648972Written as Gastrografin
- Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel ObstructionCompletedPhase 4University Hospital, RouenNCT00389116Written as gastrograffin
- (Gastrografin Use in Small Bowel Obstruction Caused by Adherences)CompletedPhase 4University of BolognaNCT00601809Written as Gastrografin®: G
As the comparator · 1 — what is tested is compared with Diatrizoate
Codes
What other systems call Diatrizoate · ClinicalTrials.gg INT007331
- MeSH (NLM) D003973DiatrizoateOne source NLM
- UNII (FDA) V5403H8VG7DIATRIZOATE SODIUMConfirmed FDA, NLM, Wikidata
- RxNorm 3321Confirmed FDA, Wikidata
- Wikidata Q27104811diatrizoate sodiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47981Diatrizoate SodiumOne source FDA
- DrugBank DBSALT000267One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003973 | Diatrizoate | One source NLM |
| UNII (FDA) | V5403H8VG7 | DIATRIZOATE SODIUM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3321 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27104811 | diatrizoate sodium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47981 | Diatrizoate Sodium | One source FDA |
| DrugBank | DBSALT000267 | — | One source Wikidata |
Also registered as diatrizoic acid (UNII 5UVC90J1LK · RxNorm 1546223).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.